Comparison of amino acid compositions of peptides eluted from HLA-B27 molecules of healthy individuals and patients with ankylosing spondylitis

被引:5
作者
Stodulková, E
Pohl, J
Man, P
Votruba, J
Capková, J
Sedlácková, M
Ivasková, E
Ivanyi, P
Flieger, M
机构
[1] Acad Sci Czech Republ, Inst Microbiol, CR-14220 Prague 4, Czech Republic
[2] Inst Clin & Expt Med, HLA Ctr, Prague 14000 4, Czech Republic
[3] Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA
[4] Acad Sci Czech Republ, Inst Mol Genet, CR-14220 Prague 4, Czech Republic
[5] Thomayer Hosp, Dept Rheumatol, Prague 14059 4, Czech Republic
关键词
HLA-B27; healthy blood donors; AS patients; Edman degradation; glutamine;
D O I
10.1016/j.imlet.2005.10.017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HLA-B27 is a relative risk factor for ankylosing spondylitis (AS) and is present in about 10% in European populations but in 95% of AS patients. Various data suggest that the HLA-B27 molecule itself could be the strongest risk factor, but there is no explanation for this association. To define differential antigen presenting features of HLA-B27 in healthy individuals and AS patients, a question that cannot be addressed by biochemical studies on cell lines, the HLA-B27 protein was purified from peripheral blood lymphocytes of AS patients and healthy controls and pool sequencing of the bound peptides was performed. Results show that peptides are rich in proline (Pro) and the content of arginine (Arg) is much lower in comparison with sequences listed in the register of peptides eluted from cell cultures. Statistically significant differences were detected in frequencies of a subset of amino acids, predominantly at positions in the middle of the peptides. The frequency of Glu was increased and Gin was decreased in peptides from AS patients. Detailed analysis of purity of the immunoisolated HLA molecules excluded that the peptides might originate from any co-purified HLA molecules other than B27. We conclude that statistically significant increase in the Glu/Gln ratio of peptides from AS patients, consistent with increased deamidation in vivo, may account for differential antigenicity of HLA-B27 in patients. Source protein(s) of deamidated peptides remain unknown. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:135 / 141
页数:7
相关论文
共 40 条
[1]   GUILT BY ASSOCIATION - HLA-B27 AND ANKYLOSING-SPONDYLITIS [J].
BENJAMIN, R ;
PARHAM, P .
IMMUNOLOGY TODAY, 1990, 11 (04) :137-142
[2]   HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum [J].
Dangoria, NS ;
DeLay, ML ;
Kingsbury, DJ ;
Mear, JP ;
Uchanska-Ziegler, B ;
Ziegler, A ;
Colbert, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (26) :23459-23468
[3]   HLA-B27:: a registry of constitutive peptide ligands [J].
de Castro, JAL ;
Alvarez, I ;
Marcilla, M ;
Paradela, A ;
Ramos, M ;
Sesma, L ;
Vázquez, M .
TISSUE ANTIGENS, 2004, 63 (05) :424-445
[4]   Identification of tissue transglutaminase as the autoantigen of celiac disease [J].
Dieterich, W ;
Ehnis, T ;
Bauer, M ;
Donner, P ;
Volta, U ;
Riecken, EO ;
Schuppan, D .
NATURE MEDICINE, 1997, 3 (07) :797-801
[5]  
Dulphy N, 1999, J IMMUNOL, V162, P3830
[6]   Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes [J].
Fiorillo, MT ;
Meadows, L ;
DAmato, M ;
Shabanowitz, J ;
Appella, E ;
Sorrentino, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (02) :368-373
[7]  
García F, 1998, TISSUE ANTIGENS, V51, P1
[8]   Lack of carboxyl-terminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated with ankylosing spondylitis [J].
Garcia, F ;
Marina, A ;
deCastro, JAL .
TISSUE ANTIGENS, 1997, 49 (03) :215-221
[9]   HLA-B27-RESTRICTED CD8 T-CELLS DERIVED FROM SYNOVIAL-FLUIDS OF PATIENTS WITH REACTIVE ARTHRITIS AND ANKYLOSING-SPONDYLITIS [J].
HERMANN, E ;
YU, DTY ;
ZUMBUSCHENFELDE, KHM ;
FLEISCHER, B .
LANCET, 1993, 342 (8872) :646-650
[10]   Dual HLA-B27 subtype-dependent conformation of a self-peptide [J].
Hülsmeyer, M ;
Fiorillo, MT ;
Bettosini, F ;
Sorrentino, R ;
Saenger, W ;
Ziegler, A ;
Uchanska-Zlegler, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (02) :271-281